Effects of polymorphisms in ABCG2, SLCO1B1, SLC10A1 and CYP2C9/19 on plasma concentrations of rosuvastatin and lipid response in Chinese patients (Q46062183)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Effects of polymorphisms in ABCG2, SLCO1B1, SLC10A1 and CYP2C9/19 on plasma concentrations of rosuvastatin and lipid response in Chinese patients	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/23930675

Effects of polymorphisms in ABCG2, SLCO1B1, SLC10A1 and CYP2C9/19 on plasma concentrations of rosuvastatin and lipid response in Chinese patients (English)

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/23930675

0 references

author name string

Hon-Kit Lee

1

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/23930675

Miao Hu

2

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/23930675

Sandra Sh Lui

3

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/23930675

Chung-Shun Ho

4

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/23930675

Chun-Kwok Wong

5

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/23930675

Brian Tomlinson

6

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/23930675

publication date

1 August 2013

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/23930675

Pharmacogenomics

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/23930675

14

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/23930675

11

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/23930675

1283-1294

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/23930675

Polymorphisms in four genes related to triglyceride and HDL-cholesterol levels in the general Japanese population in 2000.

1 reference

https://api.crossref.org/works/10.2217%2FPGS.13.115

21 January 2018

Evaluation of inhibitory drug interactions during drug development: genetic polymorphisms must be considered

1 reference

https://api.crossref.org/works/10.2217%2FPGS.13.115

21 January 2018

A review of the pharmacologic and pharmacokinetic aspects of rosuvastatin

1 reference

https://api.crossref.org/works/10.2217%2FPGS.13.115

21 January 2018

The ABCG2 transporter and its relations with the pharmacokinetics, drug interaction and lipid-lowering effects of statins

1 reference

https://api.crossref.org/works/10.2217%2FPGS.13.115

21 January 2018

The influence of SLCO1B1 (OATP1B1) gene polymorphisms on response to statin therapy.

1 reference

https://api.crossref.org/works/10.2217%2FPGS.13.115

21 January 2018

Drug and bile acid transporters in rosuvastatin hepatic uptake: function, expression, and pharmacogenetics.

1 reference

https://api.crossref.org/works/10.2217%2FPGS.13.115

21 January 2018

Influence of OATP1B1 genotype on the pharmacokinetics of rosuvastatin in Koreans.

1 reference

https://api.crossref.org/works/10.2217%2FPGS.13.115

21 January 2018

Role of BCRP 421C>A polymorphism on rosuvastatin pharmacokinetics in healthy Chinese males

1 reference

https://api.crossref.org/works/10.2217%2FPGS.13.115

21 January 2018

ABCG2 polymorphism markedly affects the pharmacokinetics of atorvastatin and rosuvastatin.

1 reference

https://api.crossref.org/works/10.2217%2FPGS.13.115

21 January 2018

ABCG2 polymorphism is associated with the low-density lipoprotein cholesterol response to rosuvastatin

1 reference

https://api.crossref.org/works/10.2217%2FPGS.13.115

21 January 2018

Pharmacogenetic analysis of lipid responses to rosuvastatin in Chinese patients

1 reference

https://api.crossref.org/works/10.2217%2FPGS.13.115

21 January 2018

Genetic determinants of statin-induced low-density lipoprotein cholesterol reduction: the Justification for the Use of Statins in Prevention: an Intervention Trial Evaluating Rosuvastatin (JUPITER) trial.

1 reference

https://api.crossref.org/works/10.2217%2FPGS.13.115

21 January 2018

Membrane cholesterol selectively modulates the activity of the human ABCG2 multidrug transporter

1 reference

https://api.crossref.org/works/10.2217%2FPGS.13.115

21 January 2018

Impact of cholesterol on ABC and SLC transporters expression and function and its role in disposition variability to lipid-lowering drugs

1 reference

https://api.crossref.org/works/10.2217%2FPGS.13.115

21 January 2018

Natural allelic variants of breast cancer resistance protein (BCRP) and their relationship to BCRP expression in human intestine.

1 reference

https://api.crossref.org/works/10.2217%2FPGS.13.115

21 January 2018

Single nucleotide polymorphisms modify the transporter activity of ABCG2.

1 reference

https://api.crossref.org/works/10.2217%2FPGS.13.115

21 January 2018

Effects of the lipid environment, cholesterol and bile acids on the function of the purified and reconstituted human ABCG2 protein

1 reference

https://api.crossref.org/works/10.2217%2FPGS.13.115

21 January 2018

Sex-dependent expression and activity of the ATP-binding cassette transporter breast cancer resistance protein (BCRP/ABCG2) in liver

1 reference

https://api.crossref.org/works/10.2217%2FPGS.13.115

21 January 2018

No effect of age or gender on the pharmacokinetics of rosuvastatin: a new HMG-CoA reductase inhibitor

1 reference

https://api.crossref.org/works/10.2217%2FPGS.13.115

21 January 2018

Physiologically based pharmacokinetic modeling to predict transporter-mediated clearance and distribution of pravastatin in humans

1 reference

https://api.crossref.org/works/10.2217%2FPGS.13.115

21 January 2018

Differential effect of genetic variants of Na(+)-taurocholate co-transporting polypeptide (NTCP) and organic anion-transporting polypeptide 1B1 (OATP1B1) on the uptake of HMG-CoA reductase inhibitors

1 reference

https://api.crossref.org/works/10.2217%2FPGS.13.115

21 January 2018

Impact of OATP transporters on pharmacokinetics

1 reference

https://api.crossref.org/works/10.2217%2FPGS.13.115

21 January 2018

Interaction of angiotensin receptor type 1 blockers with ATP-binding cassette transporters

1 reference

https://api.crossref.org/works/10.2217%2FPGS.13.115

21 January 2018

Effects of acid and lactone forms of eight HMG-CoA reductase inhibitors on CYP-mediated metabolism and MDR1-mediated transport.

1 reference

https://api.crossref.org/works/10.2217%2FPGS.13.115

21 January 2018

A simple assay for the simultaneous determination of rosuvastatin acid, rosuvastatin-5S-lactone, and N-desmethyl rosuvastatin in human plasma using liquid chromatography-tandem mass spectrometry (LC-MS/MS).

1 reference

https://api.crossref.org/works/10.2217%2FPGS.13.115

21 January 2018

Different Effects of SLCO1B1 Polymorphism on the Pharmacokinetics of Atorvastatin and Rosuvastatin

1 reference

https://api.crossref.org/works/10.2217%2FPGS.13.115

21 January 2018

SLCO1B1 polymorphism and sex affect the pharmacokinetics of pravastatin but not fluvastatin

1 reference

https://api.crossref.org/works/10.2217%2FPGS.13.115

21 January 2018

Identifiers

10.2217/PGS.13.115

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/23930675

release_pscmtv65ijfcld7mx4ws3qbpzm

1 reference

https://api.fatcat.wiki/v0/release/pscmtv65ijfcld7mx4ws3qbpzm

24 November 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/23930675

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46062183&oldid=2089875349"